nVerses Capital’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-24,408
Closed -$74.2K – 16
2026
Q2
$74.2K Buy
+24,408
New +$72.9K 0.11% 254

Other funds holding ALT

nVerses Capital's ALT Position: Q3 2026 in Review

nVerses Capital sold out of Altimmune (ALT) in Q3 2026, closing a stake of 24,408 shares — an estimated $74.2K sold.

nVerses Capital first reported a position in ALT in Q2 2026 and held it in 1 quarter. The position peaked at $74.2K in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • nVerses Capital reported no remaining Altimmune position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 24,408 Altimmune shares in Q3 2026, an estimated $74.2K.
  • nVerses Capital first reported a position in Altimmune in Q2 2026 and held it in 1 quarter.
  • nVerses Capital's Altimmune position peaked at $74.2K in Q2 2026.
  • 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.